Mr. Vance has nearly 30 years of extensive leadership experience with commercial and operational expertise in the healthcare industry. He was most recently the President and Chief Executive Officer of PhotoniCare, Inc. Prior to this appointment, he was President and CEO of Titan Medical, and also served as an independent director for Titan Medical’s Board of Directors until late 2024. Previously, Mr. Vance served as President and CEO of XCath, a privately held neurovascular robotics company, having also served in similar roles at OptiScan Biomedical, Myoscience, and Hansen Medical. He strategically transformed and commercialized these businesses and markets with disruptive, enabling, and game-changing novel technologies. Mr. Vance has also executed on equity and debt financing strategies as an integral step to successful value creation and M&A events. Prior to his role at Hansen Medical, he served in various global executive leadership roles at Teleflex, Covidien, and GE HealthCare. Mr. Vance is NACD and Lean/Six Sigma Black Belt Certified, and holds both a Bachelor of Arts degree in Economics and an MBA from Marquette University.
An accomplished financial executive with extensive experience in both public company operations and capital markets, Mr. O’Toole joined AVITA Medical in 2023 as its Chief Financial Officer. Mr. O’Toole most recently served as CFO of Opiant Pharmaceuticals, a biopharmaceutical company developing treatments for addiction and drug overdose, which was acquired by Indivior in March of 2023. Prior to that, he served as CFO of Soleno Therapeutics, a company focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Prior to Soleno, Mr. O’Toole held the role of CFO for three publicly traded life sciences companies where he built and led high-performance teams. Prior to his CFO experience, he spent over 20 years in public accounting, including 16 years with Deloitte & Touche. He holds a Bachelor of Science in accounting from the University of Arizona and is a Certified Public Accountant (non-active).
Chief Legal & Compliance Officer and Corporate Secretary
Ms. Kelsey has more than 25 years of executive legal experience with expertise in M&A, securities, and corporate governance, along with a strong track record building and leading global regulatory and compliance programs. Previously, she served as Chief Legal Officer and Secretary for Amyris, Inc. and General Counsel and Secretary at Criteo S.A. Prior to these leadership roles, she was the senior securities attorney for Medtronic, Inc., the head M&A attorney for CIT Group, Inc., and the senior corporate attorney for the international conglomerate, Vivendi Universal, S.A. Before going in-house, Ms. Kelsey practiced with the law firms of White & Case and Willkie, Farr & Gallagher, in Paris and New York. A Fulbright scholar, Ms. Kelsey earned her law degree from Northwestern University Pritzker School of Law and a Bachelor of Arts degree in Political Science and International Studies from The Ohio State University, and is admitted to practice law in New York and Minnesota.
An accomplished scientist specializing in the translation of regenerative technologies for soft tissue applications, Dr. Bush currently serves as Senior Vice President of Scientific & Medical Affairs. In this capacity, she leads a dedicated team in the development and dissemination of clinical and scientific evidence supporting AVITA Medical's products, overseeing medical science liaisons, clinical educators, and medical communication specialists. Prior to joining AVITA Medical in 2017, she contributed to the expansion of Integra Life Sciences' tissue technology portfolio for wound care and surgical reconstruction. Dr. Bush has also held positions in research and development, as well as clinical sciences. She earned her Doctorate in biomedical engineering and medical physics from the University of Massachusetts and Worcester Polytechnic Institute, complemented by a Bachelor of Science in biomedical engineering from the University of Rochester.
Senior Vice President, R&D, Program Management, and Business Development
Dr. Doshi is a seasoned executive with more than 25 years of experience in the medical device and healthcare industries, specializing in research and development, program management, business development, and regulatory strategy. Since joining AVITA Medical in 2018, he has played a central role in advancing the company’s acute therapeutic wound care portfolio, leading the global launch of three products and guiding successful strategic distribution partnerships that fueled double-digit growth.
Previously, Dr. Doshi held senior leadership roles at Siemens Healthineers, where he helped drive more than 30 global product launches and was recognized as a Siemens “Top Talent,” an honor awarded to the top 1% of employees worldwide. He also held executive roles at 4Catalyzer companies, where he contributed to the development and launch of groundbreaking technologies including Butterfly Network’s iQ handheld ultrasound and Hyperfine’s Swoop portable MRI.
Dr. Doshi’s cross-functional expertise spans product development, operations, quality and regulatory affairs, intellectual property, and corporate strategy. He holds more than 15 patents, has authored over 20 peer-reviewed publications, and has been internationally recognized with the Red Dot Product Design Award and the Frost & Sullivan New Product Innovation Award.
He earned a PhD in Biomedical Physics and a BS in Cybernetics from UCLA, an MS in Medical Radiation Physics from Rosalind Franklin University, and an Executive Juris Doctorate in Law and Technology from Purdue Global Law School. He has also completed executive education programs at Harvard and Wharton’s Business Schools.
A seasoned operations executive with over 25 years of experience in the medical device industry, Mr. Melbye serves as Senior Vice President of Operations at AVITA Medical. He brings deep expertise in manufacturing, supply chain, program management, and product development across Class I, II, and III medical devices. Mr. Melbye joined AVITA Medical in 2018 and has held positions of increasing responsibility, including Senior Project Manager, Director of Project Management, and Vice President of Operations. Prior to AVITA Medical, Mr. Melbye spent over 17 years at the Alfred Mann Foundation, where he led cross-functional teams through the development and regulatory submission of complex implantable devices. Mr. Melbye earned his Bachelor of Business Administration from National University and held a Project Management Professional (PMP) certification.
With over 20 years of experience managing portfolios for pharmaceutical and medical device companies both within the U.S. and internationally, Ms. Garner serves as the Senior Vice President of Global Marketing and Strategy. In this role, she is responsible for global marketing, market access, reimbursement, sales operations, and customer service. Prior to joining AVITA Medical in 2018, she was an executive marketing director for Allergan’s medical dermatology franchise, where she led global pipeline and business development for aesthetic and therapeutic dermatology products, including BOTOX and Juvederm. Prior to that, Ms. Garner held various marketing roles at Takeda Abbott Pharmaceuticals. She received her Bachelor of Science in health services from East Carolina University.
Kate Perkins has 25 years of experience in building high-performing life sciences organizations and aligning talent strategy to commercial execution. Her career includes senior leadership roles at Celgene Corporation and Elan Pharmaceuticals, where she supported global expansion, organizational design, and major product launches. She has also led HR functions at Ultragenyx Pharmaceuticals, OncoMed Pharmaceuticals, and Nevro, guiding these organizations through growth and transformation. In addition, she has advised and supported emerging biotech and medtech companies, including Accuray, Route 92 Medical, Annexon Biosciences, Inflammatix, and Aeovian Pharmaceuticals, bringing a rare blend of global pharmaceutical expertise and hands-on experience scaling innovative, growth-stage companies.
Kate holds a Master of Science in Industrial and Organizational Psychology from Stevens Institute of Technology and a Bachelor of Arts in Communication from Rutgers University.
A regulatory and quality assurance executive with expertise across medical device, diagnostic, cosmetic, and pharmaceutical industries, Mr. Lagerquist brings nearly 30 years of experience in his role as Senior Vice President of Regulatory and Quality. Mr. Lagerquist joined AVITA Medical in 2016 to lead regulatory affairs and quality assurance. Prior to AVITA Medical, Mr. Lagerquist has held leadership roles at Allergan, Philips Oral Healthcare, and Baxter BioScience. Mr. Lagerquist earned his Bachelor of Science in biology from Humboldt State University.
Ms. VanDenburgh is an accomplished executive with more than 25 years of experience building sales teams and driving revenue growth in the healthcare industry. During her 12-year tenure at Smith & Nephew, she held senior-level sales management positions of increasing responsibility with cross-functional responsibility within their advanced wound division, which included medical devices, biologics, and dressings. Prior to that, she held a sales management position at Aureon Biosciences, where she managed and developed a new sales team, 60% of whom were her direct hires. She also held regional and divisional management roles at St. Jude Medical and Ethicon Endo-Surgery, a Johnson & Johnson company. Ms. VanDenburgh is a graduate of Virginia Tech with a Bachelor of Science in Marketing Management.